Milton Packer is Professor and Chair for the Department of Clinical Sciences at the University of Texas Southwestern Medical School, having recently moved from Columbia University in New York, where he was Chief, Division of Circulatory Physiology, Director of the Heart Failure Center, Professor of Pharmacology, and an attending physician at Presbyterian Hospital, Columbia-Presbyterian Medical Center. After receiving his MD from Jefferson Medical College in 1973, he carried out his internship and residency at the Albert Einstein College of Medicine, New York, and completed his fellowship in cardiology at Mount Sinai School of Medicine in New York.
He has taken a leading role in the development of new heart failure drugs and has been principal investigator and chairman of 14 steering committees for major clinical trials, including, more recently, COPERNICUS, REACH-1, ENABLE, AQUAVIT, REVIVE and EPOCH.
